Alan Jubane, MD
Family Medicine · Shelby, NCNPI 1710965322
Payments from drug & device makers
Across 625 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$885
- Novo Nordisk$788
- Johnson & Johnson$767
- Bayer$555
- Astellas Pharma US Inc$541
- plus $4K from 39 others
What the payments were for
- Food & beverage$9,63697%
- Education$2793%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$9,915 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 263 | $258,811 |
| OzempicSemaglutide | 176 | $205,563 |
| TrulicityDulaglutide | 144 | $184,751 |
| LinzessLinaclotide | 134 | $124,334 |
| EliquisApixaban | 122 | $118,232 |
| FarxigaDapagliflozin Propanediol | 81 | $74,289 |
| XareltoRivaroxaban | 51 | $47,003 |
| Invega SustennaPaliperidone Palmitate | 13 | $46,542 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $39,356 |
| Spiriva HandihalerTiotropium Bromide | 46 | $34,376 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 66 | $33,315 |
| MyrbetriqMirabegron | 26 | $30,418 |
| SymbicortBudesonide/Formoterol Fumarate | 99 | $26,860 |
| VraylarCariprazine Hcl | 15 | $23,592 |
| JanuviaSitagliptin Phosphate | 17 | $20,900 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta | $498 | $289,432295 claims |
| Novo NordiskOzempic, Rybelsus | $788 | $220,309190 claims |
| Lilly USA, LLCTrulicity | $369 | $184,751144 claims |
| AbbVieLinzess, Vraylar | $1,914 | $147,926149 claims |
| PfizerEliquis, Nurtec Odt | $356 | $138,088138 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $885 | $116,858201 claims |
| Johnson & JohnsonXarelto, Invega Sustenna | $767 | $93,54664 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta | $345 | $84,651134 claims |
| Astellas Pharma US IncMyrbetriq | $541 | $30,41826 claims |
| MerckJanuvia | $184 | $20,90017 claims |
| BayerKerendia | $555 | $16,01821 claims |
| UCB, Inc.Neupro | $21 | $9,32611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Shelby
- Christian MartinShelby$5.4M
- Stephen JonesShelby$4.5M
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.